XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $613K invested in XTL Biopharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
RhumbLine Advisers
Boston,
Massachusetts
|
$13.2K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$36.6K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$80.6K |
| 3 |
3
BNP Paribas Financial Markets
Paris,
France
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NI
1
Noked Israel
Ramat Hasharon,
Israel
| $483K | 198,888 | – | – |
|
|
2
Morgan Stanley
New York
| $80.6K | 33,151 | -6,020 | -15% |
|
|
3
Citadel Advisors
Miami,
Florida
| $36.6K | 15,435 | +1,804 | +13% |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $13.2K | 5,584 | +5,584 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| – | – | -6,954 | Closed |
|
|
6
BNP Paribas Financial Markets
Paris,
France
| – | – | -300 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|